{"transactions":[{"id":862090,"issuer":{"id":62843,"kind":"organization","name":"Ventyx Biosciences, Inc.","symbol":"VTYX"},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T16:15:13.000Z","date":"2026-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":350000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated January 7, 2026 (as it may be amended from time to time, the \"Merger Agreement\"), by and among Ventyx Biosciences, Inc. (\"Issuer\") , Eli Lilly and Company (\"Parent\"), and Parent's wholly owned subsidiary, RYLS Merger Corporation ( \"Merger Sub\"),  the Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger and becoming a wholly owned subsidiary of the Parent."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the total number of shares of common stock subject to the option, multiplied by (ii) the excess, if any, of the Per Share Price over the exercise price per share of such option, without interest and less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the total number of shares of common stock subject to the option, multiplied by (ii) the excess, if any, of the Per Share Price over the exercise price per share of such option, without interest and less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":1.95,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001922353-26-000002","document":"form4-03042026_090306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000192235326000002/form4-03042026_090306.xml","form_type":"4"}},{"id":862089,"issuer":{"id":62843,"kind":"organization","name":"Ventyx Biosciences, Inc.","symbol":"VTYX"},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T16:15:13.000Z","date":"2026-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":85000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated January 7, 2026 (as it may be amended from time to time, the \"Merger Agreement\"), by and among Ventyx Biosciences, Inc. (\"Issuer\") , Eli Lilly and Company (\"Parent\"), and Parent's wholly owned subsidiary, RYLS Merger Corporation ( \"Merger Sub\"),  the Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger and becoming a wholly owned subsidiary of the Parent."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the total number of shares of common stock subject to the option, multiplied by (ii) the excess, if any, of the Per Share Price over the exercise price per share of such option, without interest and less any applicable withholding taxes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted into the right to receive an amount in cash equal to (i) the total number of shares of common stock subject to the option, multiplied by (ii) the excess, if any, of the Per Share Price over the exercise price per share of such option, without interest and less any applicable withholding taxes."}],"balance_after":0,"derivative":{"exercise_price":2.14,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001922353-26-000002","document":"form4-03042026_090306.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000192235326000002/form4-03042026_090306.xml","form_type":"4"}},{"id":862088,"issuer":{"id":62843,"kind":"organization","name":"Ventyx Biosciences, Inc.","symbol":"VTYX"},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-04T16:15:13.000Z","date":"2026-03-04","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated January 7, 2026 (as it may be amended from time to time, the \"Merger Agreement\"), by and among Ventyx Biosciences, Inc. (\"Issuer\") , Eli Lilly and Company (\"Parent\"), and Parent's wholly owned subsidiary, RYLS Merger Corporation ( \"Merger Sub\"),  the Merger Sub merged with and into the Issuer (the \"Merger\"), with the Issuer surviving the Merger and becoming a wholly owned subsidiary of the Parent."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger (the \"Effective Time\"), these shares were automatically converted solely into the right to receive cash in an amount equal to $14.00 (without interest) per share (the \"Per Share Price\"), subject to the terms and conditions of the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001922353-26-000002","document":"form4-03042026_090306.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000192235326000002/form4-03042026_090306.xml","form_type":"4"}},{"id":994117,"issuer":{"id":62843,"kind":"organization","name":"Ventyx Biosciences, Inc.","symbol":"VTYX"},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-11-19T16:30:10.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":1.03,"value":3090.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Ventyx Biosciences, Inc. 2021 Employee Stock Purchase Plan (\"2021 ESPP\"), for the ESPP Purchase Period (as defined in the 2021 ESPP) of May 15, 2025 through November 14, 2025. This transaction is also exempt under Rule 16b-3(c)."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the 2021 ESPP) ended, and the shares were acquired, on the Exercise Date (as defined in the 2021 ESPP) of November 17, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the 2021 ESPP, these shares were purchased based on 85% of the closing price on May 15, 2025."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001193125-25-288157","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000119312525288157/ownership.xml","form_type":"4"}},{"id":1145675,"issuer":{"id":62843,"kind":"organization","name":"Ventyx Biosciences, Inc.","symbol":"VTYX"},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-05-16T18:40:27.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":3000,"price":1.03,"value":3090.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Ventyx Biosciences, Inc. 2021 Employee Stock Purchase Plan (\"2021 ESPP\"), for the ESPP Purchase Period (as defined in the 2021 ESPP) of November 15, 2024 through May 15, 2025. This transaction is also exempt under Rule 16b-3(c)."},{"field":"date","element":"transactionDate","label":"F2","text":"The relevant Offering Period (as defined in the 2021 ESPP) ended, and the shares were acquired, on the Exercise Date (as defined in the 2021 ESPP) of May 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In accordance with the 2021 ESPP, these shares were purchased based on 85% of the closing price on May 15, 2025."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0000950170-25-073812","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000095017025073812/ownership.xml","form_type":"4"}},{"id":1315407,"issuer":{"id":62843,"kind":"organization","name":"Ventyx Biosciences, Inc.","symbol":"VTYX"},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-03T18:50:35.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One forty-eighth (1/48th) of the total shares subject to the Option shall vest each month following the Vesting Commencement Date (as defined below) on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date. The Vesting Commencement Date is January 2, 2025."}],"balance_after":85000,"derivative":{"exercise_price":2.14,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001415889-25-000645","document":"form4-01032025_110132.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000141588925000645/form4-01032025_110132.xml","form_type":"4"}},{"id":1434979,"issuer":{"id":62843,"kind":"organization","name":"Ventyx Biosciences, Inc.","symbol":"VTYX"},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-13T16:48:33.000Z","date":"2024-08-12","kind":"grant","planned":false,"acquired":true,"shares":350000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Option shall vest on the one year anniversary of the date of grant (the \"Vesting Commencement Date\"), and 1/48th of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each such date."}],"balance_after":350000,"derivative":{"exercise_price":1.95,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":350000},"source":{"system":"sec-edgar","filing":"0001415889-24-021189","document":"form4-08132024_080829.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000141588924021189/form4-08132024_080829.xml","form_type":"4"}},{"id":1569569,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-19T16:09:54.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":203000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares monthly beginning on April 15, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":203000,"derivative":{"exercise_price":1.5,"underlying":"Common Stock","underlying_shares":203000},"source":{"system":"sec-edgar","filing":"0001415889-24-008491","document":"form4-03192024_080347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000141588924008491/form4-03192024_080347.xml","form_type":"4"}},{"id":1646616,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T19:34:59.000Z","date":"2024-02-10","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-24-003637","document":"form4-02142024_120249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000141588924003637/form4-02142024_120249.xml","form_type":"4"}},{"id":1646615,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2024-02-13T19:34:59.000Z","date":"2022-02-10","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":15000,"derivative":{"underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-24-003637","document":"form4-02142024_120249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000141588924003637/form4-02142024_120249.xml","form_type":"4"}},{"id":1646614,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-13T19:34:59.000Z","date":"2022-02-10","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests as of 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":25000,"derivative":{"exercise_price":4.52,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-24-003637","document":"form4-02142024_120249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000141588924003637/form4-02142024_120249.xml","form_type":"4"}},{"id":1646613,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-02-13T19:34:59.000Z","date":"2021-08-16","kind":"grant","planned":false,"acquired":true,"shares":130000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests as to 25% of the total shares on August 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":130000,"derivative":{"exercise_price":10.84,"expiration_date":"2031-08-15","underlying":"Common Stock","underlying_shares":130000},"source":{"system":"sec-edgar","filing":"0001415889-24-003637","document":"form4-02142024_120249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000141588924003637/form4-02142024_120249.xml","form_type":"4"}},{"id":1646612,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-13T19:34:59.000Z","date":"2024-02-13","kind":"sale","planned":false,"acquired":false,"shares":1638,"price":0.97,"value":1588.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a \"sell to cover\" transaction."}],"balance_after":48631,"source":{"system":"sec-edgar","filing":"0001415889-24-003637","document":"form4-02142024_120249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000141588924003637/form4-02142024_120249.xml","form_type":"4"}},{"id":1646611,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2024-02-13T19:34:59.000Z","date":"2024-02-10","kind":"exercise","planned":false,"acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."}],"balance_after":50269,"source":{"system":"sec-edgar","filing":"0001415889-24-003637","document":"form4-02142024_120249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000141588924003637/form4-02142024_120249.xml","form_type":"4"}},{"id":1693358,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2024-01-03T16:21:31.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"100% of the total restricted stock units vested on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"100% of the total restricted stock units vested on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-24-000369","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000120919124000369/doc4.xml","form_type":"4"}},{"id":1693357,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-03T16:21:31.000Z","date":"2024-01-02","kind":"sale","planned":false,"acquired":false,"shares":15813,"price":0.91,"value":14389.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a \"sell to cover\" transaction."}],"balance_after":45269,"source":{"system":"sec-edgar","filing":"0001209191-24-000369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000120919124000369/doc4.xml","form_type":"4"}},{"id":1693356,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2024-01-03T16:21:31.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,082 shares acquired on May 13, 2022, 4,000 shares acquired on May 15, 2023, and 4,000 shares acquired on November 15, 2023 under the 2020 Employee Stock Purchase Plan."}],"balance_after":61082,"source":{"system":"sec-edgar","filing":"0001209191-24-000369","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000120919124000369/doc4.xml","form_type":"4"}},{"id":1925427,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-04-05T19:28:35.000Z","date":"2023-03-15","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/48 of the total shares monthly beginning on April 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":1.08,"expiration_date":"2033-03-14","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-23-023478","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000120919123023478/doc4.xml","form_type":"4"}},{"id":2118328,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-11-14T16:22:48.000Z","date":"2022-11-10","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"100% of the total RSUs will vest on December 31, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-22-056613","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000120919122056613/doc4.xml","form_type":"4"}},{"id":2231650,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-06-15T17:24:49.000Z","date":"2022-06-13","kind":"grant","acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as of 1/36 of the total shares monthly beginning on July 13, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":136000,"derivative":{"exercise_price":2.29,"expiration_date":"2032-06-12","underlying":"Common Stock","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001209191-22-037053","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000120919122037053/doc4.xml","form_type":"4"}},{"id":2294104,"issuer":{"id":7829,"kind":"organization","name":"Passage BIO, Inc."},"owners":[{"id":62855,"kind":"person","name":"Forman Mark S","position":1,"cik":"0001922353","reported_name":"Forman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Options (right to buy)","published_at":"2022-04-20T16:22:34.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":136000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on April 18, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":136000,"derivative":{"exercise_price":2.61,"expiration_date":"2032-04-17","underlying":"Common Stock","underlying_shares":136000},"source":{"system":"sec-edgar","filing":"0001209191-22-024938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1922353/000120919122024938/doc4.xml","form_type":"4"}}]}